Active, not recruiting
Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck
NCT02769520
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- UCSD Moores Cancer Center La Jolla, California, United States
- University of California San Francisco San Francisco, California, United States
- University of California Los Angeles Torrance, California, United States